Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Lau

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Ophthalmology|April 16, 2023
Symptoms and Satisfaction Levels Associated with Intraocular Lens Implants in the Monofocal and Premium IOL Patient-Reported Outcome Measure StudySamuel Masket, Flora Lum, Scott MacRae, et al.
Hepatology International|April 12, 2020
Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantationHongling Liu, Xi He, Yudong Wang, et al.
Ophthalmology|April 13, 2023
Development of a Patient-Reported Outcome Measure to Assess Symptoms Associated with Cataract Surgery and Intraocular Lens ImplantsRon D Hays, Scott MacRae, Jack Holladay, et al.
Metabolism Open|April 23, 2021
Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up studyDong Ji, Guo-Feng Chen, Xiao-Xia Niu, et al.
Hepatology International|July 4, 2024
Risk of hepatocellular carcinoma occurrence after antiviral therapy for patients with chronic hepatitis C Infection: a systematic review and meta-analysisGui-Ji Lv, Dong Ji, Lingxiang Yu, et al.
Hepatology International|November 11, 2020
APASL practical recommendations for the management of hepatocellular carcinoma in the era of COVID-19Shuichiro Shiina, Rino A Gani, Osamu Yokosuka, et al.
ILIVER|July 10, 2025
Prednisolone therapy accelerates recovery of severe drug-induced liver injury: A prospective, randomized controlled studyFang-Jiao Song, Hong-Ling Liu, Ying Sun, et al.
Gastroenterology|June 10, 2004
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapyBettina Werle-Lapostolle, Scott Bowden, Stephen Locarnini, et al.
Alimentary Pharmacology & Therapeutics|April 3, 2026
HBsAg Quantification-Based Models for Predicting Hepatocellular Carcinoma Risk in Nucleos(t)ide Analogs-Experienced Patients With Chronic Hepatitis B: The HBsAg-HCC ScoreYi-Fan Guo, Xiao-Xia Niu, Le Li, et al.
Hepatology International|July 23, 2016
Twelve-week ribavirin-free direct-acting antivirals for treatment-experienced Chinese with HCV genotype 1b infection including cirrhotic patientsDong Ji, Guo-Feng Chen, Cheng Wang, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Ophthalmology|April 16, 2023
Symptoms and Satisfaction Levels Associated with Intraocular Lens Implants in the Monofocal and Premium IOL Patient-Reported Outcome Measure StudySamuel Masket, Flora Lum, Scott MacRae, et al.
Hepatology International|April 12, 2020
Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantationHongling Liu, Xi He, Yudong Wang, et al.
Ophthalmology|April 13, 2023
Development of a Patient-Reported Outcome Measure to Assess Symptoms Associated with Cataract Surgery and Intraocular Lens ImplantsRon D Hays, Scott MacRae, Jack Holladay, et al.
Metabolism Open|April 23, 2021
Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up studyDong Ji, Guo-Feng Chen, Xiao-Xia Niu, et al.
Hepatology International|July 4, 2024
Risk of hepatocellular carcinoma occurrence after antiviral therapy for patients with chronic hepatitis C Infection: a systematic review and meta-analysisGui-Ji Lv, Dong Ji, Lingxiang Yu, et al.
Hepatology International|November 11, 2020
APASL practical recommendations for the management of hepatocellular carcinoma in the era of COVID-19Shuichiro Shiina, Rino A Gani, Osamu Yokosuka, et al.
ILIVER|July 10, 2025
Prednisolone therapy accelerates recovery of severe drug-induced liver injury: A prospective, randomized controlled studyFang-Jiao Song, Hong-Ling Liu, Ying Sun, et al.
Gastroenterology|June 10, 2004
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapyBettina Werle-Lapostolle, Scott Bowden, Stephen Locarnini, et al.
Alimentary Pharmacology & Therapeutics|April 3, 2026
HBsAg Quantification-Based Models for Predicting Hepatocellular Carcinoma Risk in Nucleos(t)ide Analogs-Experienced Patients With Chronic Hepatitis B: The HBsAg-HCC ScoreYi-Fan Guo, Xiao-Xia Niu, Le Li, et al.
Hepatology International|July 23, 2016
Twelve-week ribavirin-free direct-acting antivirals for treatment-experienced Chinese with HCV genotype 1b infection including cirrhotic patientsDong Ji, Guo-Feng Chen, Cheng Wang, et al.
Pageof 10